A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.

The newly approved medicines in 2024 from Massachusetts companies range from a schizophrenia drug to a gene therapy for ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $468.09, demonstrating a +0.94% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.38% gain on the ...

Vertex Pharmaceuticals (Vertex) is a biotechnology company that ... Vertex is headquartered in Boston, Massachusetts, the US. The company reported revenues of (US Dollars) US$9,869.2 million for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

"The 6000 lb. Diaries with Dr. Now" follows 10 morbidly obese individuals who have reached a ... [+] combined weight of 6,000 pounds, and are fighting to lose it and transform their lives.

Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading session, marking a -0.99% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.3%.

In a filing in Norfolk Superior Court, Read’s attorneys defended the credentials and opinion of Dr. Marie Russell ... backed her SUV into O’Keefe, a Boston police officer she was dating ...

A new Still G.I.N. By Dre and Snoop ad drops on Tuesday, Dec. 10, and it features rappers Dr. Dre and Snoop Dogg “meeting” music legends Frank Sinatra and Sammy Davis Jr. The cinematic spot ...